Volume 20 Issue 12
Dec.  2022
Turn off MathJax
Article Contents
Article Navigation >  Chinese Journal of General Practice  > 2022  >  20(12): 2055-2058
WANG Ying, YUN Chun-mei, LIU Ke-han, JIA Pei-feng, LIU Hong-yan, GAO Xiao-yu. Clinical characteristic analysis of different inflammatory phenotypes in bronchial asthma[J]. Chinese Journal of General Practice, 2022, 20(12): 2055-2058. doi: 10.16766/j.cnki.issn.1674-4152.002768
Citation: WANG Ying, YUN Chun-mei, LIU Ke-han, JIA Pei-feng, LIU Hong-yan, GAO Xiao-yu. Clinical characteristic analysis of different inflammatory phenotypes in bronchial asthma[J]. Chinese Journal of General Practice, 2022, 20(12): 2055-2058. doi: 10.16766/j.cnki.issn.1674-4152.002768
shu

Clinical characteristic analysis of different inflammatory phenotypes in bronchial asthma

doi: 10.16766/j.cnki.issn.1674-4152.002768

  • Department of Pulmonary and Critical Care Medicine, Inner Mongolia People' s Hospital/National Key Laboratory for Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease/Inner Mongolia Autonomous Region Key Laboratory of Respiratory Diseases, Huhhot, Inner Mongolia 010017, China

Funds:

 201802161

 201703

 2019BS08

 2021MS08165

 2021MS08112

  • Received Date: 2021-03-18
    Available Online: 2023-02-07
    Abstract
  •   Objective  To analyse the clinical characteristics of different inflammatory phenotypes of bronchial asthma (BA) and compare the clinical indicators before and after treatment, so as to provide a basis for clinical diagnosis and treatment of asthma.  Methods  A total of 110 asthma patients in chronic duration in the Outpatient Ward of Inner Mongolia People ' s Hospital were recruited from July 2018 to January 2019, and divided into four groups with different airway inflammation phenotypes based on the results of induced sputum, such as eosinophilic asthma (EA), neutrophilic asthma, mixed granulocytic asthma (MGA) and paucigranulocytic asthma. The differences in clinical characteristics were compared, and the clinical indicators before and after treatment were compared and analysed.  Results  No significant differences were observed in the clinical symptoms and control level between inflammatory phenotypes (both P>0.05). Compared with the other groups, the EA group showed a significantly increased exhaled nitric oxide (FeNO) and significantly decreased FEV1 /FVC and FEV1 % (all P < 0.05). The number of eosinophil (Eos) was positively correlated trend with the values of FeNO (r=0.541), and negatively correlated with the values of FEV1 /FVC and FEV1 % (r=-0.301, -0.284). The clinical indicators of asthma before treatment and 1 month after treatment (low-dose inhale corticosteroids+long-acting inhale β2-agonist) were compared. The Eos and FeNO in EA and MGA groups significantly decreased after treatment compared with those before treatment (EA: t=3.564, 6.761; MGA: t=3.068, 4.093, all P < 0.05). FEV1 /FVC and FEV1 % in the EA group were significantly higher than those before treatment (t=-2.755, -2.729, both P < 0.05).  Conclusion  Lung function decline is pronounced in the Eos-increased phenotype (EA), and FeNO is closely associated with eosinophilic inflammation. Low-dose ICS+LABA is effective in Eos-increasing phenotype asthma patients.

     

    • FullText(HTML)
  • loading
    • References(19)
  • [1]
    HUANG K, YANG T, XU J Y, et al. Prevalence, risk factors, and management of asthma in China: A national cross-sectional study[J]. Lancet, 2019, 394(10196): 407-418. doi: 10.1016/S0140-6736(19)31147-X
    [2]
    中华医学会呼吸病学分会哮喘学组. 支气管哮喘防治指南(2020年版)[J]. 中华结核和呼吸杂志, 2020, 43(12): 1023-1048. doi: 10.3760/cma.j.cn112147-20200618-00721

    Asthma Group, Respiratory Branch of Chinese Medical Association. Guidelines for the prevention and treatment of bronchial asthma (2020 edition)[J]. Chinese Journal of Tuberculosis and Respiratory Diseases, 2020, 43(12): 1023-1048. doi: 10.3760/cma.j.cn112147-20200618-00721
    [3]
    NANDA A, WASAN A N. Asthma in adults[J]. Med Clin North Am, 2020, 104(1): 95-108. doi: 10.1016/j.mcna.2019.08.013
    [4]
    陈华萍, 王子, 李瑾, 等. 诱导痰细胞分类检查技术及应用[J]. 中华肺部疾病杂志(电子版), 2020, 13(3): 399-402. doi: 10.3877/cma.j.issn.1674-6902.2020.03.026

    CHEN H P, WANG Z, LI J, et al. Classification and application of induced sputum cells[J]Chinese Journal of Lung Diseases(Electronic Edition), 2020, 13(3): 399-402. doi: 10.3877/cma.j.issn.1674-6902.2020.03.026
    [5]
    张亚丽, 蒋毅. 诱导痰检测技术在支气管哮喘中的应用进展[J]. 山东医药, 2022, 62(7): 93-96. https://www.cnki.com.cn/Article/CJFDTOTAL-SDYY202207024.htm

    ZHANG Y L, JIANG Y. Application progress of induced sputum detection technology in bronchial asthma[J]. Shandong Medical Journal, 2022, 62(7): 93-96. https://www.cnki.com.cn/Article/CJFDTOTAL-SDYY202207024.htm
    [6]
    窦晓宾, 吴铁峰, 蔡振荡. 效应T细胞、调节T细胞失衡与支气管哮喘患儿病情程度的相关性及对疾病控制情况的预测价值[J]. 中华全科医学, 2019, 17(4): 597-600. doi: 10.16766/j.cnki.issn.1674-4152.000745

    DOU X B, WU T F, CAI Z D. The correlation between the imbalance of effector T cells and regulatory T cells and the degree of disease in children with bronchial asthma and their predictive value for disease contro[J]. Chinese Journal of General Practice, 2019, 17(4): 597-600. doi: 10.16766/j.cnki.issn.1674-4152.000745
    [7]
    GAO W, HAN G J, ZHU Y J, et al. Clinical characteristics and biomarkers analysis of asthma inflammatory phenotypes[J]. Biomark Med, 2020, 14(3): 211-222. doi: 10.2217/bmm-2019-0487
    [8]
    SCHOETTLER N, STREK M E. Recent advances in severe asthma: From phenotypes to personalized medicine[J]. Chest, 2020, 157(3): 516-528. doi: 10.1016/j.chest.2019.10.009
    [9]
    BROOKS C R, VAN DALEN C J, HARDING E, et al. Effects of treatment changes on asthma phenotype prevalence and airway neutrophil function[J]. BMC Pulm Med, 2017, 17(1): 169. doi: 10.1186/s12890-017-0511-6
    [10]
    白黎峰. 呼出气一氧化氮联合肺功能指标对支气管哮喘诊断的临床研究[J]. 医药论坛杂志, 2021, 42(9): 115-118. https://www.cnki.com.cn/Article/CJFDTOTAL-HYYX202109031.htm

    BAI L F. Clinical study of exhaled nitric oxide combined with pulmonary function indexes in the diagnosis of bronchial asthma[J]. Journal of Medical Forum, 2021, 42(9): 115-118. https://www.cnki.com.cn/Article/CJFDTOTAL-HYYX202109031.htm
    [11]
    RAMAKRISHNAN R K, AL HEIALY S, HAMID Q. Role of IL-17 in asthma pathogenesis and its implications for the clinic[J]. Expert Rev Respir Med, 2019, 13(11): 1057-1068. doi: 10.1080/17476348.2019.1666002
    [12]
    屈小雪, 刘雅莉, 王健美, 等. 不同炎症表型哮喘常用生物学标志物进展[J]. 临床与病理杂志, 2019, 39(6): 1349-1355. https://www.cnki.com.cn/Article/CJFDTOTAL-WYSB201906033.htm

    QU X X, LIU YL, WANG J M, et al. Advances in commonly used biomarkers for asthma with different inflammatory phenotypes[J]. Journal of Clinical and Pathological Research, 2019, 39(6): 1349-1355. https://www.cnki.com.cn/Article/CJFDTOTAL-WYSB201906033.htm
    [13]
    王子江. 532例哮喘患者的气道炎症表型及临床特征分析[J]. 山东医药, 2016, 56(9): 46-48. https://www.cnki.com.cn/Article/CJFDTOTAL-SDYY201609018.htm

    WANG Z J. Analysis of phenotype and clinical characteristics of airway inflammation in 532 asthma patients[J]. Shandong Medical Journal, 2016, 56(9): 46-48. https://www.cnki.com.cn/Article/CJFDTOTAL-SDYY201609018.htm
    [14]
    RUPANI H, CHAUHAN A J. Measurement of FeNO in asthma: What the hospital doctor needs to know[J]. Br J Hosp Med (Lond), 2019, 80(2): 99-104.
    [15]
    MOGENSEN I, ALVING K, JACINTO T, et al. Simultaneously elevated FeNO and blood eosinophils relate to asthma morbidity in asthmatics from NHANES 2007-12[J]. Clin Exp Allergy, 2018, 48(8): 935-943.
    [16]
    GANS M D, GAVRILOVA T. Understanding the immunology of asthma: Pathophysiology, biomarkers, and treatments for asthma endotypes[J]. Paediatr Respir Rev, 2020, 36: 118-127.
    [17]
    ERJEFALT J S. Unravelling the complexity of tissue inflammation in uncontrolled and severe asthma[J]. Curr Opin Pulm Med, 2019, 25(1): 79-86.
    [18]
    KAUR R, CHUPP G. Phenotypes and endotypes of adult asthma: Moving toward precision medicine[J]. J Allergy Clin Immunol, 2019, 144(1): 1-12.
    [19]
    RHYOU H I, NAM Y H. Predictive factors of response to inhaled corticosteroids in newly diagnosed asthma: A real-world observational study[J]. Ann Allergy Asthma Immunol, 2020, 125(2): 177-181.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)  / Tables(4)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (319) PDF downloads(11) Cited by()
    Proportional views
    Related

    Address：No. 287, Changhuai Road, Bengbu, Anhui Province, 233004, P.R.ChinaphoneNo：0552-3066635； 0552-3051890Email：zhqkyx@163.com

    Copyright © Chinese Journal of General Practice皖ICP备2020018345号-2

    Supported by: Beijing Renhe Information Technology Co., Ltd.    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return